What is the indication for sodium sulfate, potassium sulfate, and magnesium sulfate oral solution (Suprep) and what are its side effects? | Rounds What is the indication for sodium sulfate, potassium sulfate, and magnesium sulfate oral solution (Suprep) and what are its side effects? | Rounds
Loading...

What is the indication for sodium sulfate, potassium sulfate, and magnesium sulfate oral solution (Suprep) and what are its side effects?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Indication for Suprep (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution

Suprep is indicated for cleansing of the colon as a preparation for colonoscopy in adult patients. [1]

Common side effects

Most common adverse reactions in adults include overall discomfort, abdominal distension, abdominal pain, nausea, and vomiting. [1] In a randomized active-controlled trial using the split-dose (2-day) regimen, the most common reported adverse reactions in adults were: overall discomfort (54%), abdominal distension (40%), abdominal pain (36%), nausea (36%), and vomiting (8%). [1]

Less common adverse reactions

Less common adverse reactions reported include atrioventricular (AV) block (1 case) and creatine kinase (CK) increase. [1]

Important serious adverse reactions (listed in warnings/precautions)

Serious fluid and serum chemistry abnormalities are described elsewhere in the prescribing information. [1] Cardiac arrhythmias are described elsewhere in the prescribing information. [1] Seizures are described elsewhere in the prescribing information. [1] Risk of renal injury is described elsewhere in the prescribing information. [1] Colonic mucosal ulcerations and ischemic colitis are described elsewhere in the prescribing information. [1] Significant gastrointestinal disease is described elsewhere in the prescribing information. [1] Aspiration risk is described elsewhere in the prescribing information. [1]

Pediatric indication note

Pediatric use information is approved for the Suprep Bowel Prep Kit for pediatric patients aged 12 years and older, but this specific product labeling does not include the pediatric information. [1]

Related Questions